Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman ImmunityBio, Executive Chairman of Los Angeles Times, shared a post on X:
“Unless we wake up, China’s speed in regulatory approval is their advantage, we will lose our lead and be dependent on next generation drugs from rest of world.
Urgent need to change old world regulatory bureaucracy.
Pharma is investing in China and USA biotech at risk.”
More posts featuring Pharma.